Skip to main content
KBS_Icon_questionmark link-ico

 

Mishto Lab

We investigate the implications of proteasome-catalysed peptide splicing in tumour immunology, autoimmunity and in the CD8+ T cell response during infection, with the long-term aim to improve the efficacy of immunotherapy and vaccine development.

Furthermore, by applying a multi-scale and multi-disciplinary approach – thereby combining in silico, in vitro and in vivo strategies – we study how proteasome isoforms regulate the inflammation in the intracellular and extracellular space by degrading proteins and producing (pro)inflammatory peptides.

PhD students

Bei fang Teo (PhD)

Our partners

Blood Cancer UK logo

Blood Cancer UK

Max Planck Institute logo

Max Planck Institute